Potential gastrointestinal uses of somatostain and its synthetic analogue octreotide.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 1975156.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Octreotide is a long-acting analogue of somatostatin which has been FDA approved for symptomatic carcinoid syndrome and for vasoactive intestinal peptide-producing tumors. Somatostatin and octreotide have significant effects on gastrointestinal physiology which may be beneficial for a variety of disorders. This paper will review the currently available literature on the use of somatostatin and octreotide in non-neoplastic disorders of the gastrointestinal tract.
Medical subject headings
- Gastrointestinal Diseases
- Octreotide
- Somatostatin